S. N. Sofia, “Role of phosphodiesterase-3 inhibitor in cardiorespiratory fitness and functional class of patients with pulmonary hypertension: A randomized, double-blind, placebo-controlled trial”, Narra J, vol. 5, no. 1, p. e1301, Jan. 2025.